FDA reported on Wednesday: serious genital infections for people who are on sodium-glucose cotransporter-2 (SGLT2) inhibitors. So far, 1 death and 11 hospitals
The following are some of the companies: Johnson & Johnson’s Invokana (canagliflozin), Eli Lilly & Co’s Jardiance (empagliflozin), as well those from Bristol-Myers Squibb, AstraZeneca Plc, Merck & Co, and Pfizer Inc.
Reuters Health News 08/30/2018
